A Novel Access to Arylated and Heteroarylated Beta-Carboline Based PDE5 Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|6|6|374-387

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.6, Iss.6, 2010-11, pp. : 374-387

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PDE5 Inhibitors and their Applications

By  

Current Medicinal Chemistry, Vol. 17, Iss. 24, 2010-08 ,pp. : 2564-2587

Bentham Science Publishers

Access to resources Recommend Favorite

Novel PDE5 inhibitors for the treatment of male erectile dysfunction

By Kalsi JS   Bahadur G   Muneer A   Ozturk O   Christopher N   Ralph DJ   Minhas S  

Reproductive BioMedicine Online, Vol. 7, Iss. 4, 2003-10 ,pp. : 456-461

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

PDE-5 Inhibitors: Clinical Points

By  

Current Drug Targets, Vol. 16, Iss. 5, 2015-05 ,pp. : 420-426

Bentham Science Publishers

Access to resources Recommend Favorite

PDE5 Inhibitors in the Treatment of LUTS

By  

Current Pharmaceutical Design, Vol. 15, Iss. 30, 2009-10 ,pp. : 3502-3505

Bentham Science Publishers

Access to resources Recommend Favorite

Novel phosphodiesterase-5 (PDE5) inhibitors in the alleviation of erectile dysfunction due to diabetes and ageing-induced oxidative stress

By Gur Serap   Sikka Suresh C   Hellstrom Wayne JG  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 6, 2008-06 ,pp. : 855-864

Informa Healthcare

Access to resources Recommend Favorite